Coronary vasomotor and blood flow responses to isoflavone-intact soy protein in subjects with coronary heart disease or risk factors for coronary heart disease
Résumé
Animal data suggest favourable coronary vasomotor actions of isoflavones however the effects of isoflavones on the human coronary circulation are undetermined. We therefore investigated the effects of short-term isoflavone-intact soy protein ingestion on basal coronary arterial tone and stimulated vasoreactivity and blood flow in patients with coronary heart disease (CHD) or risk factors for CHD. Seventy-one subjects were randomised, double-blind, to isoflavone-intact soy protein (active; n=33, mean±SD, aged 58±8 years) or isoflavone-free placebo (n=38, aged 61±8 years) for 5 days prior to coronary angiography. In 25 of these subjects stimulated coronary blood flow was calculated from flow velocity, measured using intracoronary Doppler, and coronary luminal diameter before and after intracoronary adenosine, acetylcholine (ACh) and isosorbide dinitrate (ISDN) infusions. Basal and stimulated coronary artery luminal diameters were measured using quantitative coronary angiography. Serum concentrations of isoflavones genistein, daidzein and equol were increased by active treatment (p<0.001, p<0.001 and p=0.03 respectively). Basal mean luminal diameter was not significantly different between groups (2.9±0.7 vs 2.73±0.44mm, active vs placebo; p=0.31). There was no difference in luminal diameter, flow velocity and volume flow responses to adenosine, ACh or ISDN between groups. Active supplement had no effect on basal coronary artery tone or stimulated coronary vasoreactivity or blood flow compared with placebo. Our results suggest that short-term consumption of isoflavone-intact soy protein is neither harmful nor beneficial to the coronary circulation of humans with CHD or risk factors for CHD. These data are consistent with recent cautions placed on the purported health benefits of plant sterols.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...